These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12562041)

  • 1. Interventions to improve adherence to antiretroviral therapy.
    Tuldrà A; Wu AW
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S154-7. PubMed ID: 12562041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences.
    Ickovics JR; Meade CS
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S98-102. PubMed ID: 12562029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Rueda S; Park-Wyllie LY; Bayoumi AM; Tynan AM; Antoniou TA; Rourke SB; Glazier RH
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD001442. PubMed ID: 16855968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to HAART among patients with HIV: breakthroughs and barriers.
    Ickovics JR; Meade CS
    AIDS Care; 2002 Jun; 14(3):309-18. PubMed ID: 12042076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence assessment to highly active antiretroviral therapy.
    Tsasis P
    AIDS Patient Care STDS; 2001 Mar; 15(3):109-15. PubMed ID: 11313023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
    Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
    AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
    Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to HIV regimens: 10 vital lessons.
    Williams AB
    Am J Nurs; 2001 Jun; 101(6):37-43; quiz 44. PubMed ID: 11441760
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study.
    Sidat M; Fairley C; Grierson J
    AIDS Patient Care STDS; 2007 Jul; 21(7):509-20. PubMed ID: 17651032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting adherence to highly active antiretroviral therapy and protected sex among people living with HIV/AIDS: the role of patient-provider communication in Rio de Janeiro, Brazil.
    Fehringer J; Bastos FI; Massard E; Maia L; Pilotto JH; Kerrigan D
    AIDS Patient Care STDS; 2006 Sep; 20(9):637-48. PubMed ID: 16987050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Real-Time Adherence Feedback to Enhance Communication About Adherence to Antiretroviral Therapy: Patient and Clinician Perspectives.
    Hill LM; Golin CE; Pack A; Carda-Auten J; Wallace DD; Cherkur S; Farel CE; Rosen EP; Gandhi M; Asher Prince HM; Kashuba ADM
    J Assoc Nurses AIDS Care; 2020; 31(1):25-34. PubMed ID: 31033629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategies to optimize adherence to antiretroviral treatment. Interventions in the therapeutic regimen].
    Knobel H; Guelar A
    Enferm Infecc Microbiol Clin; 2004 Feb; 22(2):106-12. PubMed ID: 14756993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time, self and the medication day: a closer look at the everyday work of 'adherence'.
    McCoy L
    Sociol Health Illn; 2009 Jan; 31(1):128-46. PubMed ID: 19170973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.